PLC Systems cuts workforce, hires firm to examine “strategic alternatives.”
PLC Systems Inc. (OTC:PLCSF) announced a series of moves aimed at keeping it afloat, hiring a New York investment firm, slashing its workforce and outsourcing the production of its flagship product....
View ArticleClik here to view.
PLC Systems might not see 2011
PLC Systems Inc. (OTC:PLCSF) is on the ropes after ending 2009 in rough shape and is looking to drum up enough cash to stay in business. PLC’s accountants are worried the company isn’t bringing in...
View ArticleClik here to view.
PLC Systems wins USPTO patent allowances
PLC Systems Inc. (OTC:PLCSF) got some badly-needed good news when the U.S. Patent and Trademark Office issued notices of allowance for a pair of patents covering the Franklin, Mass.-based company’s...
View ArticleClik here to view.
PLC looking for some TLC from investors to settle cash woes
PLC Medical Systems Inc.’s (OTC:PLCSF) continues to bleed cash as both its top and bottom lines slid during the first quarter of 2010. The Franklin, Mass.-based medical device maker’s reported sales...
View ArticleClik here to view.
PLC Systems narrows Q2 losses despite sales slide
PLC Systems Inc. (OTC:PLCSF) was able to boost its bottom line during the second quarter, but revenues dropped and the company stayed in the black. The Franklin, Mass.-based company reported a net...
View ArticleMYTHOS RenalGuard Trial Demonstrates Greater Efficacy Than Current Standard...
PRESS RELEASE PLC Systems Inc. (OTC:PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today announced that updated results from the MYTHOS...
View ArticleClik here to view.
PLC Systems offloads angiogenesis system to Canadian firm
PLC Systems Inc. (OTC:PLCSF) entered into a deal to sell off its transmyocardial revascularization assetts to Novadaq Technologies Inc. (TSX:NDQ) for $1 million in cash. The transaction could be worth...
View ArticleClik here to view.
Earnings roundup: Bacterin sales triple, but losses increase
Bacterin sales triple, but losses increase Bacterin International Holdings Inc. (OTC:BIHI) reported a loss of $9.0 million, or 26 cents per diluted share, on sales of $4.2 million during the three...
View ArticleClik here to view.
CardioFocus reels in $14 million | Funding roundup
CardioFocus Inc. drummed up in nearly $14 million in a hoped-for $15.6 million funding round. The Marlborough, Mass.-based company is developing a visually guided balloon catheter that uses a rotating...
View ArticleClik here to view.
Bovie Medical names new president, shuffles board | Personnel moves
Bovie Medical Corp. (NYSE:BVX) announced a flurry of personnel moves in its corner office and board room. The company said current president and CEO Andrew Makrides will relinquish his title of...
View ArticleClik here to view.
ACC 2011: Drug-eluting stents can help in bypass surgeries
Drug-eluting stents can help patients who underwent open heart bypass surgery, according to new data, meaning they need fewer revascularization procedures after their surgeries. Dr. Julinda Mehilli of...
View ArticleClik here to view.
Ingen CEO jailed for kickbacks scheme | Personnel moves
Ingen Technologies Inc.’s (OTC:IGNT) former CEO, Scott Sand, is headed to the slammer for his role in a plot involving the illegal manipulation of his company’s stock price. The Yucaipa, Calif.-based...
View ArticleClik here to view.
Cambridge Heart’s Q1 sales slide on Cardiac Science buyout | Earnings Roundup
Cambridge Heart Inc. (OTC:CAMH) took a hit during the first quarter, as last year’s acquisition of partner Cardiac Science helped drive sales down 3.2 percent, even as it prepped an offering to raise...
View ArticleClik here to view.
PLC ramps up for RenalGuard trials | Research roundup
PLC Systems Inc. (OTC:PLCSF) announced that it will commence its pivotal U.S. trial for the RenalGuard contrast-induced nephropathy treatment. CIN is a form of acute renal failure caused by exposure...
View ArticleClik here to view.
Zoll shares spike 23 percent on record 2011 sales and earnings | Earnings...
Zoll reported record numbers in its top and bottom line for fiscal year 2011, sending its stock up 23 percent overnight. Zoll shares were trading at $44.35 in the early afternoon today, up from last...
View ArticleClik here to view.
FDA clears Smith & Nephew’s Pico pocket NPWT device | Regulatory Roundup
Smith & Nephew (NYSE:SNN) won a nod from the FDA for its Pico negative-pressure wound therapy system. The British orthopedics giant’s wound care division said the FDA cleared the device for use in...
View ArticleClik here to view.
Will Intuitive Surgical’s stock ever stop? | Wall Street Beat
Shares of Intuitive Surgical (NSDQ:ISRG) hit an all-time high yesterday of $529.70 and beat it today, as investors sent the shares to $531.35 apiece this morning. The spikes followed an upgrade by...
View ArticleClik here to view.
Medtronic wins Canadian approval for brain-stim therapy for epileptics |...
Medtronic wins Canadian approval for brain-stim epilepsy therapy Medtronic (NYSE:MDT) touted Health Canada approval for its deep brain stimulation therapy for refractory epilepsy patients. The DBS...
View ArticleClik here to view.
World Heart’s 2011 sales go negative | Earnings roundup
World Heart’s 2011 sales go negative World Heart Corp. (NSDQ:WHRT) posted losses of $3.8 million, or 14¢ per share, on negative sales of $143,000 for 2011. That compares with losses of $20.5 million,...
View ArticleClik here to view.
PLC Systems touts $1M now, $1M later for U.S. RenalGuard trials | Funding...
PLC Systems touts $1M now, $1M later for RenalGuard trials Milford, Mass.-based PLC Systems raised $1 million in funding to support U.S. clinical trials for its RenalGuard system, designed to help...
View ArticleClik here to view.
FDA approves 1st Type 2 diabetes drug | Wall Street Beat
The FDA approved a 1st-of-its-kind treatment for Type 2 diabetes, Johnson & Johnson‘s (NYSE:JNJ) Invokana, with the federal watchdog agency citing it as a pioneer in a new class of diabetes drug....
View ArticleClik here to view.
TAVI: PLC Systems launches RenalGuard trial
PLC Systems (PINK:PLCSF) said its RenalGuard device was used in a new clinical trial evaluating the device in treating patients with acute kidney failure undergoing transcatheter aortic valve...
View ArticleClik here to view.
PLC Systems raises $1.8M through common stock
Medical device maker PLC Systems (PINK:PLCSF) touted a new $1.75 million raise, which the company plans to use to fund its ongoing U.S. pivotal trial for the RenalGuard system. PLC sold more than 29...
View ArticleClik here to view.
PLC Systems lands Japanese OK for RenalGuard trial
PLC Systems (OTC:PLCSF) won approval from the Japanese Ministry of Health, Labor & Welfare for a clinical trial of its RenalGuard device. The single-arm, 60-patient trial of patients with existing...
View ArticleClik here to view.
PLC Systems reports revenue surge in 3rd quarter
PLC Systems (OTC:PLCSF) is cutting down on its losses, thanks in part to strong revenues during the 3rd quarter. PLC Systems posted losses of $609,000, or -1¢ per share, on sales of $348,000 for the 3...
View Article